Related references
Note: Only part of the references are listed.Therapeutic potential of CAR T cell in malignancies: A scoping review
Ali Zarezadeh Mehrabadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Katja Weisel et al.
CLINICAL DRUG INVESTIGATION (2022)
CAR Treg: A new approach in the treatment of autoimmune diseases
Seyedeh Ameneh Beheshti et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells
J. Joseph Melenhorst et al.
NATURE (2022)
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR
Haneen Shalabi et al.
BLOOD (2022)
Novel insights in CAR-NK cells beyond CAR-T cell technology; promising advantages
Hamidreza Ebrahimiyan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Kevin Pan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation
Wei Zuo et al.
FRONTIERS IN IMMUNOLOGY (2022)
CAR-NK cells for cancer immunotherapy: from bench to bedside
Leisheng Zhang et al.
BIOMARKER RESEARCH (2022)
Macrophage-Based Approaches for Cancer Immunotherapy
Nicholas R. Anderson et al.
CANCER RESEARCH (2021)
Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
Ekaterina Zmievskaya et al.
BIOMEDICINES (2021)
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential
Mansour Poorebrahim et al.
CANCER GENE THERAPY (2021)
Engineering advanced logic and distributed computing in human CAR immune cells
Jang Hwan Cho et al.
NATURE COMMUNICATIONS (2021)
HSC and iPS cell-derived CAR-NK cells as reliable cell-based therapy solutions
Jonathan Arias et al.
STEM CELLS TRANSLATIONAL MEDICINE (2021)
Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy
Lorenzo Lindo et al.
FRONTIERS IN IMMUNOLOGY (2021)
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
Christopher Sloas et al.
FRONTIERS IN IMMUNOLOGY (2021)
Implementing Logic Gates for Safer Immunotherapy of Cancer
Mohammed Azharuddin Savanur et al.
FRONTIERS IN IMMUNOLOGY (2021)
Current Perspectives on Off-The-Shelf Allogeneic NK and CAR-NK Cell Therapies
Erica L. Heipertz et al.
FRONTIERS IN IMMUNOLOGY (2021)
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Nawid Albinger et al.
GENE THERAPY (2021)
Human NK cells: From development to effector functions.
Arosh Shavinda Perera Molligoda Arachchige
INNATE IMMUNITY (2021)
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy
Enrico Kittel-Boselli et al.
CANCERS (2021)
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
Joseph H. Choe et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner et al.
BLOOD CANCER JOURNAL (2021)
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
Maxwell Y. Lee et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity
Morgane Boulch et al.
SCIENCE IMMUNOLOGY (2021)
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin
Nengzhi Pang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Jesus G. Berdeja et al.
LANCET (2021)
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Jay Y. Spiegel et al.
NATURE MEDICINE (2021)
Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs
Ehsan Moghanloo et al.
TRANSLATIONAL ONCOLOGY (2021)
Selective Cytotoxicity of Single and Dual Anti-CD19 and Anti-CD138 Chimeric Antigen Receptor-Natural Killer Cells against Hematologic Malignancies
Sudjit Luanpitpong et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
Mark Dapash et al.
CANCERS (2021)
Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan-Tong Liu et al.
THERANOSTICS (2021)
Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy
Fengzhen Mo et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin Lymphoma
Jeremy S. Abramson
TRANSFUSION MEDICINE REVIEWS (2020)
Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer
Bihui Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells
Tatsuki Ueda et al.
CANCER SCIENCE (2020)
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
Nina Shah et al.
LEUKEMIA (2020)
The significance of exosomes in the development and treatment of hepatocellular carcinoma
Xin Li et al.
MOLECULAR CANCER (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
mRNA Transfection-Induced Activation of Primary Human Monocytes and Macrophages: Dependence on Carrier System and Nucleotide Modification
Hanieh Moradian et al.
SCIENTIFIC REPORTS (2020)
Recent progress in and challenges in cellular therapy using NK cells for hematological malignancies
Junji Tanaka et al.
BLOOD REVIEWS (2020)
Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity
Jing Ni et al.
IMMUNITY (2020)
High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
Stephan Mueller et al.
FRONTIERS IN IMMUNOLOGY (2020)
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
Hanren Dai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Suppression of FVIII-Specific Memory B Cells by Chimeric BAR Receptor-Engineered Natural Regulatory T Cells
Alessandra De Paula Pohl et al.
FRONTIERS IN IMMUNOLOGY (2020)
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Raju K. Vaddepally et al.
CANCERS (2020)
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky et al.
NATURE BIOTECHNOLOGY (2020)
Infectious Complications Following CD19 Chimeric Antigen Receptor T-cell Therapy for Children, Adolescents, and Young Adults
Surabhi B. Vora et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
Margery Gang et al.
BLOOD (2020)
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Mihe Hong et al.
CANCER CELL (2020)
Immune Sensing Mechanisms that Discriminate Self from Altered Self and Foreign Nucleic Acids
Eva Bartok et al.
IMMUNITY (2020)
Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation
Lixia Sheng et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies
Craig W. Freyer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Dual Targeting to Overcome Current Challenges in Multiple Myeloma CAR T-Cell Treatment
Jort J. van der Schans et al.
FRONTIERS IN ONCOLOGY (2020)
Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris
Jinmin Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Designed protein logic to target cells with precise combinations of surface antigens
Marc J. Lajoie et al.
SCIENCE (2020)
Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function
Benjamin Salzer et al.
NATURE COMMUNICATIONS (2020)
Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4
Arezoo Jamali et al.
FRONTIERS IN IMMUNOLOGY (2020)
Bispecific Chimeric Antigen Receptor T Cell Therapy for B Cell Malignancies and Multiple Myeloma
Robert J. Cronk et al.
CANCERS (2020)
Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?
Muhammad Sadeqi Nezhad et al.
FRONTIERS IN IMMUNOLOGY (2020)
Next-generation cell therapies: the emerging role of CAR-NK cells
Rafet Basar et al.
BLOOD ADVANCES (2020)
MOTO-CARs™: A novel macrophage-based chimeric antigen receptor technology
Michelle Hannah Townsend et al.
CANCER RESEARCH (2020)
A review of cancer immunotherapy: from the past, to the present, to the future
K. Esfahani et al.
CURRENT ONCOLOGY (2020)
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
Li Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy
Anja Feldmann et al.
ONCOIMMUNOLOGY (2020)
Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes
Li Zhang et al.
JOURNAL OF AUTOIMMUNITY (2019)
Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting
Shivani Srivastava et al.
CANCER CELL (2019)
Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus
Rita Kansal et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Recent success and limitations of immune checkpoint inhibitors for cancer: a lesson from melanoma
Margaret Ottaviano et al.
VIRCHOWS ARCHIV (2019)
Engineering and Design of Chimeric Antigen Receptors
Sonia Guedan et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
A safe and potent anti-CD19 CAR T cell therapy
Zhitao Ying et al.
NATURE MEDICINE (2019)
Targeting Tumor-Associated Macrophages in Cancer
Paulina Pathria et al.
TRENDS IN IMMUNOLOGY (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes
Michel Tenspolde et al.
JOURNAL OF AUTOIMMUNITY (2019)
Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer
Xiang Ao et al.
JOURNAL OF IMMUNOTHERAPY (2019)
Multi-Specific CAR Targeting to Prevent Antigen Escape
Zachary Walsh et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
Tuning the Tumor Myeloid Microenvironment to Fight Cancer
Nadine S. Jahchan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing
Tiziano Ingegnere et al.
FRONTIERS IN IMMUNOLOGY (2019)
Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
Kyle B. Lupo et al.
CANCERS (2019)
Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix
Wenlong Zhang et al.
BRITISH JOURNAL OF CANCER (2019)
Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
Shengnan Yu et al.
MOLECULAR CANCER (2019)
Targeting cardiac fibrosis with engineered T cells
Haig Aghajanian et al.
NATURE (2019)
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR
Sara Ghorashian et al.
NATURE MEDICINE (2019)
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Xiao Han et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function
Hillary G. Caruso et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
CARdiac Immunotherapy: T Cells Engineered to Treat the Fibrotic Heart
Ronald J. Vagnozzi et al.
MOLECULAR THERAPY (2019)
CD 137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo
Xiaojun Tang et al.
ONCOTARGETS AND THERAPY (2019)
A simple and efficient method for the generation of a porcine alveolar macrophage cell line for high-efficiency Porcine reproductive and respiratory syndrome virus 2 infection
Xiangpeng Wang et al.
JOURNAL OF VIROLOGICAL METHODS (2019)
Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
L. Herrera et al.
SCIENTIFIC REPORTS (2019)
Current Progress in CAR-T Cell Therapy for Solid Tumors
Shuo Ma et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
Jang Hwan Cho et al.
CELL (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice
Robert L. Kruse et al.
CYTOTHERAPY (2018)
Macrophage plasticity, polarization, and function in health and disease
Abbas Shapouri-Moghaddam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
Christopher C. Kloss et al.
MOLECULAR THERAPY (2018)
Regulatory T cells in autoimmune disease
Margarita Dominguez-Villar et al.
NATURE IMMUNOLOGY (2018)
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Theodoros Giavridis et al.
NATURE MEDICINE (2018)
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects
Yuki Kagoya et al.
NATURE MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Chimeric antigen receptor T-cell approaches to HIV cure
Anne-Sophie Kuhlmann et al.
CURRENT OPINION IN HIV AND AIDS (2018)
Chimeric antigen receptors that trigger phagocytosis
Meghan A. Morrissey et al.
ELIFE (2018)
Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies
Shangjun Sun et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flavia Castro et al.
FRONTIERS IN IMMUNOLOGY (2018)
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Krijn K. Dijkstra et al.
CELL (2018)
Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis
Liliana Michelle Gomez Mendez et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Cancer immunotherapy with CART cells - behold the future
Charlotte Graham et al.
CLINICAL MEDICINE (2018)
Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy
Noelle Frey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages
Shicheng Su et al.
CELL (2018)
Integrin CD11b activation drives anti-tumor innate immunity
Michael C. Schmid et al.
NATURE COMMUNICATIONS (2018)
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
Qing Zhang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Chimeric Antigen Receptors Based on Low Affinity Mutants of FcεRI Re-direct T Cell Specificity to Cells Expressing Membrane IgE
Dana E. Ward et al.
FRONTIERS IN IMMUNOLOGY (2018)
Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22
Haiying Qin et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
Engineered FVIII-expressing cytotoxic T cells target and kill FVIII-specific B cells in vitro and in vivo
Kalpana Parvathaneni et al.
BLOOD ADVANCES (2018)
FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T-and B-cell responses to FVIII
Jeongheon Yoon et al.
BLOOD (2017)
Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells
Stephan Kloss et al.
HUMAN GENE THERAPY (2017)
Tumor-associated macrophages: from basic research to clinical application
Li Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
The Plasticity and Stability of Regulatory T Cells during Viral-Induced Inflammatory Lesions
Siddheshvar Bhela et al.
JOURNAL OF IMMUNOLOGY (2017)
Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes
Sigal Fishman et al.
MOLECULAR THERAPY (2017)
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Jennifer L. Guerriero et al.
NATURE (2017)
Donor CD19 CART cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity
Arnab Ghosh et al.
NATURE MEDICINE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of Asthma
Jelena Skuljec et al.
FRONTIERS IN IMMUNOLOGY (2017)
Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
Federico Simonetta et al.
FRONTIERS IN IMMUNOLOGY (2017)
Global Manufacturing of CAR T Cell Therapy
Bruce L. Levine et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma
Ashley Orillion et al.
CLINICAL CANCER RESEARCH (2017)
Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma
Sarah Oelsner et al.
CYTOTHERAPY (2017)
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein
Giuseppe A. Sautto et al.
GUT (2016)
Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
Christoph M. Hammers et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy
Vijay G. Bhoj et al.
BLOOD (2016)
Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
Kole T. Roybal et al.
CELL (2016)
Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
Leonardo Morsut et al.
CELL (2016)
Macrophages: sentinels and regulators of the immune system
Lars Franken et al.
CELLULAR MICROBIOLOGY (2016)
Single-dose rituximab in refractory lupus nephritis
P. Kotagiri et al.
INTERNAL MEDICINE JOURNAL (2016)
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape (Publication with Expression of Concern. See vol. 129, pg. 3464, 2019)
Meenakshi Hegde et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
Marco Ruella et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau et al.
NATURE (2016)
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda et al.
NATURE (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
Christoph T. Ellebrecht et al.
SCIENCE (2016)
Harnessing NK Cell Memory for Cancer Immunotherapy
Todd A. Fehniger et al.
TRENDS IN IMMUNOLOGY (2016)
TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype
Fan Zhang et al.
ONCOTARGET (2016)
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Anna-Maria Georgoudaki et al.
CELL REPORTS (2016)
Cytomegalovirus-Infected Cells Resist T Cell Mediated Killing in an HLA-Recognition Independent Manner
Julia Proff et al.
FRONTIERS IN MICROBIOLOGY (2016)
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
Eugenia Zah et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Toxicity and management in CAR T-cell therapy
Challice L. Bonifant et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment
Christopher G. Pena et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy
Katrin Toepfer et al.
JOURNAL OF IMMUNOLOGY (2015)
Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity
Li Liu et al.
JOURNAL OF VIROLOGY (2015)
Contributions of B cells to lupus pathogenesis
Allison Sang et al.
MOLECULAR IMMUNOLOGY (2014)
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells
Dan Blat et al.
MOLECULAR THERAPY (2014)
Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
Pappanaicken R. Kumaresan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes
Li Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo
Xiaojun Tang et al.
JOURNAL OF BIOMEDICAL RESEARCH (2014)
Progress toward inducing immunologic tolerance to factor VIII
David W. Scott et al.
BLOOD (2013)
Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin
Marie Jaguin et al.
CELLULAR IMMUNOLOGY (2013)
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
Dominic E. Sanford et al.
CLINICAL CANCER RESEARCH (2013)
Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein
S. Bobadilla et al.
GENE THERAPY (2013)
Recruitment of a Myeloid Cell Subset (CD11b/Gr1mid) via CCL2/CCR2 Promotes the Development of Colorectal Cancer Liver Metastasis
Lei Zhao et al.
HEPATOLOGY (2013)
Tissue-Resident Macrophages Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating Monocytes
Daigo Hashimoto et al.
IMMUNITY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
PD-1-and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
Victor D. Fedorov et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
Zakaria Grada et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
Samantha C. Gouw et al.
BLOOD (2012)
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
Moa Fransson et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
Antonio Curti et al.
BLOOD (2011)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J. Brentjens et al.
BLOOD (2011)
Instability of Foxp3 Expression Limits the Ability of Induced Regulatory T Cells to Mitigate Graft versus Host Disease
Amy Beres et al.
CLINICAL CANCER RESEARCH (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
Eleni G. Iliopoulou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux et al.
SCIENCE (2010)
Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor
Eran Elinav et al.
GASTROENTEROLOGY (2009)
Developing a Novel Model System to Target Insulin-Reactive CD8 T Cells
Gwen S. Scott et al.
IMMUNOLOGY OF DIABETES V: FROM BENCH TO BEDSIDE (2008)
T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes
Felix Bohne et al.
GASTROENTEROLOGY (2008)
Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: Implications for CSF blockade in inflammation
Andrew J. Fleetwood et al.
JOURNAL OF IMMUNOLOGY (2007)
The role of lymphocytes in the pathogenesis of asthma and COPD
Simonetta Baraldo et al.
CURRENT MEDICINAL CHEMISTRY (2007)
NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells
JL Upshaw et al.
NATURE IMMUNOLOGY (2006)
Dectin-1: a signalling non-TLR pattern-recognition receptor
GD Brown
NATURE REVIEWS IMMUNOLOGY (2006)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Mechanisms of lymphocyte migration in autoimmune disease
MU Norman et al.
TISSUE ANTIGENS (2005)
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
RJ Brentjens et al.
NATURE MEDICINE (2003)
A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy
SG Deeks et al.
MOLECULAR THERAPY (2002)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus-infected subjects
RT Mitsuyasu et al.
BLOOD (2000)
Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages
A Sica et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
